Literature DB >> 18367980

Current developments in drug testing in oral fluid.

Kristof Pil1, Alain Verstraete.   

Abstract

In the last few years, significant developments have occurred on the key issues involved in oral fluid drug testing. New pharmacokinetic studies have been conducted, optimal cutoffs have been proposed, and new studies have examined the correlation between oral fluid drug concentrations and impairment. Recent studies (eg, the discovery of the presence of THC-COOH in oral fluid) can contribute to solve the issue of false-positive results caused by passive exposure to marijuana. Reliable point-of-care drug testing is still problematic, especially for cannabinoids and benzodiazepines. To date, there is no device that allows both reliable and practical point-of-care testing. The importance of liquid chromatography- tandem mass spectrometry in confirmation analysis has increased over the last several years. It can be expected that this trend will continue because the low sample volumes make simultaneous detection of different drug classes with limited sample preparation necessary. Literature on proficiency testing to ensure reliability and comparability of results is limited. Oral fluid has become an important sample type in driving under the influence research, and the first legal random drug testing program in oral fluid since 2004 has been organized in Victoria. It can be expected that the role of oral fluid as an alternative matrix will keep increasing in the future.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18367980     DOI: 10.1097/FTD.0b013e318167d563

Source DB:  PubMed          Journal:  Ther Drug Monit        ISSN: 0163-4356            Impact factor:   3.681


  4 in total

Review 1.  Current knowledge on cannabinoids in oral fluid.

Authors:  Dayong Lee; Marilyn A Huestis
Journal:  Drug Test Anal       Date:  2013-08-25       Impact factor: 3.345

2.  Undiagnosed Drug Misuse among Admissions to Psychiatric Day Treatment and Prediction of Early Exit.

Authors:  Stephen Magura; Jessaca Spybrook; Andrew Rosenblum; Chunki Fong; Cherie Villano; Howard S Vogel; Thomas Betzler
Journal:  Open Addict J       Date:  2010

Review 3.  [Initial diagnosis and treatment for poisoning].

Authors:  S Pemmerl
Journal:  Med Klin Intensivmed Notfmed       Date:  2013-08-15       Impact factor: 0.840

4.  Screening, brief intervention, and referral to treatment (SBIRT) for offenders: protocol for a pragmatic randomized trial.

Authors:  Michael L Prendergast; Jerome J Cartier
Journal:  Addict Sci Clin Pract       Date:  2013-10-23
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.